family / friend
FDA Approval of PiaSky for Pediatric Patients with PNH, Featuring Satheesh Chonat, MD
Dr. Satheesh Chonat explains how pediatric patients with PNH, or Paroxysmal Nocturnal Hemoglobinuria, may be treated with PiaSky in this recording. Listen now or read transcript below.
Nutrition and Bone Marrow Failure
Low-Risk MDS
In this webinar, Dr. Andrew Matthews discusses Low Risk MDS, current treatments and what's on the treatment horizon. Dr. Matthews took many questions from the live audience.
NMDP and CIBMTR share new, promising stem cell transplantation trial data using mismatched, unrelated donors at the 2024 EHA Congress
MINNEAPOLIS, June 14, 2024 — NMDPSM, a global nonprofit leader in cell therapy, and the CIBMTR® (Center for International Blood and Marrow Transplant Research®) announced interim results from the ACCESS trial as an oral abstract during the European Hematology Association (EHA) Annual Meeting in Madrid, Spain.
Blood and guts: how the intestinal microbiome shapes hematopoiesis and treatment of hematologic disease
Abstract
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
Key Points
Trends in Volumes and Survival After Hematopoietic Cell Transplantation in Racial/Ethnic Minorities
Key Points
The number of autoHCT and alloHCT grew faster in Non-Hispanic African Americans and Hispanics compared to Non-Hispanic Whites.
Survival after autoHCT and alloHCT improved over time for all racial/ ethnic groups, though African Americans have worse outcomes.
PNH and Non-Transplant Therapies - 2023 New Haven Patient and Family Conference
Dr. Nicolai Podoltsev describes options available for patients with PNH who could choose non-transplant treatments.
Managing Low Blood Counts - 2023 New Haven Patient and Family Conference
Lisa Barbarotta describes techniques to help manage low blood counts in this session.